Saginaw, MINCT05698212Now EnrollingIRB Ready

Endometriosis Clinical Trial in Saginaw, MI

Access cutting-edge endometriosis treatment through this clinical trial at a research site in Saginaw. Study-provided care at no cost to qualified participants.

Sponsored by Hera Biotech, Inc.

Quick Self-Assessment

See if you qualify for this Saginaw location

Preparing your pre-screening questions…

Expert Care in Saginaw

Access endometriosis specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related endometriosis treatment provided free

Apply for This Saginaw Location

Check if you qualify for this endometriosis clinical trial in Saginaw, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Saginaw

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Saginaw site if eligible
  4. 4Begin participation

About This Endometriosis Study in Saginaw

This study is testing a way to diagnose endometriosis using a uterine tissue biopsy (similar to a pap smear) as opposed to undergoing laparoscopy surgery. The tissue is sent to lab for cellular analysis with a proprietary AI (artificial intelligence) technology.

Sponsor: Hera Biotech, Inc.

Who Can Participate

Inclusion Criteria

Able to understand and provide informed consent.
Natural born female of childbearing potential.
Age between 18 and 50, inclusive.
Not pregnant at Visit 0 (screening) or Visit 1 (day of procedure).
Free of systemic or pelvic disorder that, in the opinion of the investigator, may interfere with the tissue collection procedure, analysis of the tissue or increase the risk to subject.
Must not have received excision or ablation surgical procedure or treatment, such as gonadotropin-releasing hormone (GnRH), for endometriosis within the past 12 months.
For Cohort 1 and 2:
Suspected of having endometriosis, or previously diagnosed with endometriosis, and currently recommended for laparoscopic surgery by physician.
Must have laparoscopic surgery within 60 days after screening Visit 0 and any time after the endometrial biopsy is obtained on Visit 1 (including the same day), or a laparoscopy on record within the 12 months prior to Visit 0 for diagnosis only.
Surgical report from prior laparoscopy must indicate that endometriosis was not treated with surgical ablation or excision.
Subjects will be assigned to Cohort 1 or 2 based on diagnosis and staging results from laparoscopy.
Or for Cohort 3:
Not suspected of having endometriosis
no previous diagnosis or symptoms of endometriosis, who have had a laparoscopy for another reason, such as tubal ligation or other abdominal procedure, within the past 12 months prior to screening Visit 0,
or laparoscopy to be completed within 60 days after screening Visit 0 and any time after the endometrial biopsy is obtained on Visit 1 (including the same day).
Surgeon's report must have no supplemental observations of endometriosis lesions or diagnosis. Subjects will be assigned to Cohort 3.

Exclusion Criteria

Younger than 18 or 51 years or older.
Surgical history of hysterectomy.
Has received excision or ablation surgical procedure or treatment, such as gonadotropin-releasing hormone (GnRH), for endometriosis within the past 12 months.
Cohort 3: Prior diagnosis of endometriosis, or surgical note from prior laparoscopy that indicates endometriosis lesions were observed.
Has a BMI 40 or above.
Is currently taking a blood thinner medication.
Currently, pregnant, breast feeding, or has given birth in the last 6 months.
Diagnosed with HIV, AIDS, hepatitis A, B, or C, or has active malignancy.
Has a complicating condition that would pose a hazard to tissue handling.
Undergoing fertility or hormone therapy treatments.
History or evidence of uterine fibroids.
History of reproductive cancer.
Has a condition that, in the opinion of the investigator, would confound tissue collection or analysis.
Has an active pelvic infection or other infections contra-indicated for laparoscopy.
Has participated in any interventional clinical trial in the previous 90 days in which an investigational drug was administered.
Has a history of alcohol or illegal drug/substance abuse, or suspected alcohol or illegal drug/substance abuse in the past two years.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Saginaw?

Yes, this clinical trial (NCT05698212) has an active research site in Saginaw, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Endometriosis Treatment Options in Saginaw, MI

If you're searching for endometriosis treatment options in Saginaw, MI, this clinical trial (NCT05698212) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Saginaw research site is actively enrolling participants for this clinical trial. You'll receive care from experienced endometriosis specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all endometriosis clinical trials near you to find additional studies recruiting in your area.

More Essential Tremor Trials in Saginaw, MI

See all essential tremor clinical trials recruiting in Saginaw — not just this study.

Browse Essential Tremor Trials in Saginaw →

Browse More Trials by Condition

Essential Tremor TrialsEndometriosis TrialsMyalgic Encephalomyelitis TrialsAll Conditions →

Ready to Join in Saginaw?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Saginaw, MI